Molina Healthcare, Inc. (NYSE:MOH – Get Free Report) has earned an average rating of “Hold” from the fifteen ratings firms that are presently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $365.38.
MOH has been the topic of several analyst reports. Guggenheim initiated coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating on the stock. Stephens restated an “equal weight” rating and issued a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Mizuho boosted their price target on Molina Healthcare from $376.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. UBS Group decreased their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Finally, Wall Street Zen raised Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, April 11th.
Read Our Latest Stock Report on MOH
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. During the same quarter in the prior year, the firm earned $5.73 earnings per share. The company’s quarterly revenue was up 12.2% on a year-over-year basis. On average, research analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares in the company, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 89,169 shares of company stock valued at $28,520,995 over the last 90 days. 1.10% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Tributary Capital Management LLC lifted its position in shares of Molina Healthcare by 76.1% during the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company’s stock valued at $1,219,000 after acquiring an additional 1,811 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Molina Healthcare by 123.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company’s stock valued at $100,000 after purchasing an additional 192 shares during the period. SYM FINANCIAL Corp acquired a new stake in Molina Healthcare during the 4th quarter worth about $249,000. Summit Trail Advisors LLC purchased a new stake in Molina Healthcare during the fourth quarter valued at about $452,000. Finally, Entropy Technologies LP boosted its holdings in shares of Molina Healthcare by 58.1% in the fourth quarter. Entropy Technologies LP now owns 4,594 shares of the company’s stock worth $1,337,000 after buying an additional 1,688 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
- Five stocks we like better than Molina Healthcare
- What is the Hang Seng index?
- 3 Beaten-Down Stocks Trading 50% Below Their 52-Week Highs
- How to Invest in Small Cap Stocks
- Tesla: Why Analysts Think It Could Jump Another 47%
- How to Short Nasdaq: An Easy-to-Follow Guide
- Microsoft’s Outlook Brightens as Analysts Boost Bullish Ratings
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.